Gustavo Vasconcelos Alves

Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial

Christopher J. Sweeney, Sergio Bracarda, Cora N. Sternberg et al. · The Lancet · 2021 · 329 citations · Full text

Medicine, Oncology, Urology +12

Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

Ravindra Uppaluri, Robert I. Haddad, Yungan Tao et al. · New England Journal of Medicine · 2025 · 266 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial

Jean‐Pascal Machiels, Yungan Tao, Lisa Licitra et al. · The Lancet Oncology · 2024 · 210 citations · Full text

Medicine, Oncology, Pharmacology +16

Pembrolizumab Given Concomitantly with Chemoradiation and as Maintenance Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: KEYNOTE-412

Jean‐Pascal Machiels, Yungan Tao, Barbara Burtness et al. · Future Oncology · 2020 · 58 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Hyperparathyroidism Secondary to Hypovitaminosis D in Hypoalbuminemic Is Less Intense than in Normoalbuminemic Patients: A Prevalence Study in Medical Inpatients in Southern Brazil

Melissa Orlandin Premaor, Gustavo Vasconcelos Alves, Ligia Beatriz Crossetti et al. · Endocrine · 2004 · 37 citations

Medicine, Endocrinology, Nephrology +11